Refine Search
(318)
(515)
(567)
(645)

Irritable Bowel Syndrome - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H2 2017’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2017’, provides an overview of the Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) pipeline landscape....

Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2017’, provides an overview of the Spinocerebellar Ataxia (SCA) pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Systemic Mastocytosis - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H2 2017’, provides an overview of the Systemic Mastocytosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sy...

Gastritis - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastritis - Pipeline Review, H2 2017’, provides an overview of the Gastritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastritis, complete with a...

Hemochromatosis - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemochromatosis - Pipeline Review, H2 2017’, provides an overview of the Hemochromatosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemochromatosi...

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2017’, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline landscape.

The report provi...

Systemic Lupus Erythematosus - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2017’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Hemophilia A - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H2 2017’, provides an overview of the Hemophilia A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemophilia A, comple...

Lung Transplant Rejection - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lung Transplant Rejection - Pipeline Review, H2 2017’, provides an overview of the Lung Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Hypoparathyroidism - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypoparathyroidism - Pipeline Review, H2 2017’, provides an overview of the Hypoparathyroidism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypopara...

Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H2 2017’, provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape.

The report provides comprehensiv...

Pemphigus Vulgaris - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pemphigus Vulgaris - Pipeline Review, H2 2017’, provides an overview of the Pemphigus Vulgaris pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pemphigu...

Hypereosinophilic Syndrome - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypereosinophilic Syndrome - Pipeline Review, H2 2017’, provides an overview of the Hypereosinophilic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Fanconi Anemia - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fanconi Anemia - Pipeline Review, H2 2017’, provides an overview of the Fanconi Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fanconi Anemia, ...